Authors:
LINDENBLATT H
KRAMER E
HOLZMANNERENS P
GOUZOULISMAYFRANK E
KOVAR KA
Citation: H. Lindenblatt et al., QUANTITATION OF PSILOCIN IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ELECTROCHEMICAL DETECTION - COMPARISON OF LIQUID-LIQUID-EXTRACTION WITH AUTOMATED ONLINE SOLID-PHASE EXTRACTION, Journal of chromatography B. Biomedical sciences and applications, 709(2), 1998, pp. 255-263
Authors:
GOUZOULISMAYFRANK E
HERMLE L
THELEN B
SASS H
Citation: E. Gouzoulismayfrank et al., HISTORY, RATIONALE AND POTENTIAL OF HUMAN EXPERIMENTAL HALLUCINOGENICDRUG RESEARCH IN PSYCHIATRY, Pharmacopsychiatry, 31, 1998, pp. 63-68
Authors:
SCHRECKENBERGER M
GOUZOULISMAYFRANK E
SABRI O
ARNING C
KAISER HJ
WAGENKNECHT G
SASS H
BUELL U
Citation: M. Schreckenberger et al., CEREBRAL METABOLIC ALTERATIONS DURING ECSTASY-INDUCED EXPERIMENTAL PSYCHOSIS, The Journal of nuclear medicine, 38(5), 1997, pp. 170-170
Citation: E. Gouzoulismayfrank, ENTACTOGENS - ECSTASY (MDMA), EVE (MDE) A ND OTHER RING-SUBSTITUTED METHAMPHETAMINE DERIVATIVES - A NEW CLASS OF SUBSTANCES LABELED AS ILLEGAL DESIGNER DRUGS - REPLY, Nervenarzt, 68(11), 1997, pp. 923-923
Citation: E. Gouzoulismayfrank et al., GENERALIZED EPILEPTIC SEIZURES DURING TRE ATMENT WITH CLOZAPINE - FREQUENCY, TYPES, PROGNOSIS AND RECOMMENDED THERAPEUTIC STRATEGIES, Nervenarzt, 65(11), 1994, pp. 792-794